ID: ALA4851139

Max Phase: Preclinical

Molecular Formula: C108H138N30O21

Molecular Weight: 2192.48

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCN)NC(=O)[C@@H]1CNC(=O)c2cc3cc(c2)C(=O)N[C@H](Cc2ccc4ccccc4c2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](Cc2ccc4ccccc4c2)C(=O)N[C@@H](c2ccccc2)C(=O)N[C@@H](CCCCNC3=O)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1)C(N)=O

Standard InChI:  InChI=1S/C108H138N30O21/c1-59(88(112)142)124-98(152)78(49-60-21-5-2-6-22-60)132-95(149)75(34-19-45-121-107(115)116)125-92(146)73(32-17-42-109)128-103(157)83-57-123-90(144)70-53-69-54-71(55-70)91(145)131-80(51-62-36-38-64-25-11-13-29-67(64)47-62)100(154)137-84(58-139)104(158)135-82(56-86(111)141)101(155)134-81(52-63-37-39-65-26-12-14-30-68(65)48-63)102(156)138-87(66-27-9-4-10-28-66)105(159)130-72(31-15-16-43-119-89(69)143)94(148)133-79(50-61-23-7-3-8-24-61)99(153)129-77(40-41-85(110)140)97(151)127-74(33-18-44-120-106(113)114)93(147)126-76(96(150)136-83)35-20-46-122-108(117)118/h2-14,21-30,36-39,47-48,53-55,59,72-84,87,139H,15-20,31-35,40-46,49-52,56-58,109H2,1H3,(H2,110,140)(H2,111,141)(H2,112,142)(H,119,143)(H,123,144)(H,124,152)(H,125,146)(H,126,147)(H,127,151)(H,128,157)(H,129,153)(H,130,159)(H,131,145)(H,132,149)(H,133,148)(H,134,155)(H,135,158)(H,136,150)(H,137,154)(H,138,156)(H4,113,114,120)(H4,115,116,121)(H4,117,118,122)/t59-,72+,73+,74-,75-,76+,77+,78+,79-,80-,81-,82+,83+,84+,87+/m1/s1

Standard InChI Key:  ZQTIVTBIQLGVTK-CMLVFNFRSA-N

Associated Targets(Human)

GTPase KRas 1864 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NCI-H358 882 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Purine nucleoside phosphorylase 774 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-tyrosine phosphatase 1B 8528 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

p53-binding protein Mdm-2 4545 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SW480 6023 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NCI-H1299 3248 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DLD-1 17511 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Serum albumin 1163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NIH3T3 5395 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 2192.48Molecular Weight (Monoisotopic): 2191.0653AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Buyanova M, Cai S, Cooper J, Rhodes C, Salim H, Sahni A, Upadhyaya P, Yang R, Sarkar A, Li N, Wang QE, Pei D..  (2021)  Discovery of a Bicyclic Peptidyl Pan-Ras Inhibitor.,  64  (17.0): [PMID:34415745] [10.1021/acs.jmedchem.1c01130]

Source